Celdoxome pegylated liposomal Європейський Союз - іспанська - EMA (European Medicines Agency)

celdoxome pegylated liposomal

yes pharmaceutical development services gmbh - clorhidrato de doxorrubicina - breast neoplasms; ovarian neoplasms; multiple myeloma; sarcoma, kaposi - agentes antineoplásicos - celdoxome pegylated liposomal is indicated in adults:as monotherapy for patients with metastatic breast cancer, where there is an increased cardiac risk. or treatment of advanced ovarian cancer in women who have failed a first-line platinum-based chemotherapy regimen. in combination with bortezomib for the treatment of progressive multiple myeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant. for treatment of aids-related kaposi’s sarcoma (ks) in patients with low cd4 counts (< 200 cd4 lymphocytes/mm3) and extensive mucocutaneous or visceral disease. celdoxome pegylated liposomal may be used as first-line systemic chemotherapy, or as second line chemotherapy in aids-ks patients with disease that has progressed with, or in patients intolerant to, prior combination systemic chemotherapy comprising at least two of the following agents: a vinca alkaloid, bleomycin and standard doxorubicin (or other anthracycline).

FENTANILO MATRIX VIATRIS 50 mcg/H PARCHES TRANSDERMICOS EFG Іспанія - іспанська - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

fentanilo matrix viatris 50 mcg/h parches transdermicos efg

viatris limited - fentanilo - parche transdÉrmico - 50 microgramos/h - fentanilo 50 microgramos/h - fentanilo

MIBI INSTITUTE OF ATOMIC ENERGY 1 mg EQUIPO DE REACTIVOS PARA PREPARACION RADIOFARMACEUTICA EFG Іспанія - іспанська - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

mibi institute of atomic energy 1 mg equipo de reactivos para preparacion radiofarmaceutica efg

narodowe centrum badan jadrowych - [tetrakis (2-metoxi-2-metilpropil-1-isocianuro) cobre (i)], tetrafluoroborato de - equipo de reactivos para preparaciÓn radiofarmacÉutica - 1 mg - [tetrakis (2-metoxi-2-metilpropil-1-isocianuro) cobre (i)], tetrafluoroborato de 1 mg - tecnecio (99mtc) sestamibi